The Evolving Role of AI-powered Solutions in Medical Affairs
To better understand MAPS members’ perspectives on AI, Open Health recently convened a panel discussion on the future of data, AI, and analytics in Medical Affairs.
Using Engagement Tools Strategically to Get the Most from Advisory Boards
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
The Complete Guide to a Better Congress Experience
Medical congresses are crucial for keeping up with the latest life science industry standards and best practices – but planning is time-consuming and manual. What’s the alternative for better medical congress planning? Get the complete guide to congress planning.
Case Study: How A Global Pharma Company Targeted a KOL Engagement Strategy Specific to Rheumatology
This case study is useful for anyone working to anticipate market access issues and develop plans for launching new drugs in key markets.
Explore, Educate, Embrace: Opportunities for Medical Affairs to Impact Health Disparities & Inequities
By using the framework of Explore, Educate, Embrace we can shape our approach to Health Equity by incorporating it into our daily work.
Educating Medical Professionals for that “Rare Encounter”
Streamlining the diagnostic odyssey requires educating medical professionals to recognize “rare encounters” and engage these patients with precision and compassion.
Four Industry Trends that will Shape Medical Affairs in 2023
In 2022, organizations gained ground in patient trust, decentralized clinical trials, virtual tools, and diverse conversations throughout the product development process. So – now what?
ChatGPT is Poised to Disrupt Medical Affairs
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
How Medical Affairs Can Drive Patient-Focused Drug Development
2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
Secrets for a Successful Conference Season for Medical Affairs
Congresses are often the best opportunity to connect with HCPs and KOLs. Learn 5 secrets for success.